In this study, we have demonstrated the capacity for polymeric microstructures made of hyaluronic acid to achieve sustained delivery of the anti-fibrotic agent decorin which directly translated to therapeutic cardiac outcomes in preclinical models of I/R MI. The gene discussed is DCN; the disease is myocardial infarction.